Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment [Phase 2]
A Phase 2 study evaluating Debio 025 (alisporivir) in combination with pegylated interferon alfa-2a and ribavirin in chronic hepatitis C pat…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults [Phase 3]
Phase 3 open-label trial evaluating the efficacy and safety of sofosbuvir plus ribavirin in adults co-infected with chronic hepatitis C and …
-
CLINICAL_TRIALS trial_result · 2015-04-27Clinical Trial Update: Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001) [Phase 1, Phase 2]
Merck's IDX719, an NS5A inhibitor, was studied in healthy volunteers and patients with chronic hepatitis C in a Phase 1/2 trial (MK-1894-001…
-
EMA safety_alert · 2015-04-24EMA recommends avoidance of certain hepatitis C medicines and amiodarone together
EMA recommends avoiding concurrent use of certain hepatitis C medicines with amiodarone due to potential risk of severe bradycardia or heart…
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004) [Phase 2]
Phase 2 trial update shows safety and antiviral activity of IDX184 when combined with pegylated interferon and ribavirin in chronic hepatiti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Single-Dose Escalation Study of IDX184 in Healthy Volunteers (MK-2355-002) [Phase 1]
Phase 1 single-dose escalation study of IDX184 (MK-2355-002) in healthy volunteers to assess safety and pharmacokinetics for Hepatitis C the…
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: A Study of a New Candidate Vaccine Against Hepatitis C Virus (HCV) [Phase 1]
Phase 1 study of a new candidate hepatitis C vaccine sponsored by ReiThera Srl has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) [Phase 2]
Phase 2 trial assessing samatasvir in combination with simeprevir and/or TMC647055/ritonavir (with or without ribavirin) for 12 weeks in chr…
-
CLINICAL_TRIALS trial_result · 2015-04-23Clinical Trial Update: Study of a Novel Therapeutic Vaccine for Hepatitis C Virus [Phase 1]
Completed Phase 1 study evaluating ReiThera Srl's novel therapeutic vaccine for hepatitis C virus.
-
CLINICAL_TRIALS trial_result · 2015-04-22Clinical Trial Update: Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123) [Phase 1]
Phase 1 clinical trial evaluating RNA derived from liver tissue in patients with chronic hepatitis C has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-17Clinical Trial Update: Safety and Efficacy Study of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Genotype 1 and 3 Chronic HCV Infection [Phase 3]
Phase 3 trial evaluating sofosbuvir plus ribavirin in treatment-naive adults with genotype 1 or 3 chronic hepatitis C completed; results wer…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of VX-135 With Ribavirin in Treatment-Naïve Subjects With Chronic Hepatitis C [Phase 2]
Phase 2 study to evaluate the safety and efficacy of VX-135 with ribavirin in treatment-naïve chronic hepatitis C subjects has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: 3-Year Observational Virology Follow-up Study in Subjects Who Participated in Studies of Idenix Anti-HCV, Direct Acting Antivirals
A terminated clinical trial update presenting a 3-year observational virology follow-up in participants from Idenix anti-HCV direct-acting a…
-
CLINICAL_TRIALS trial_result · 2015-04-15Clinical Trial Update: A Phase 1/2 Study of CF102 in Patients With Chronic Hepatitis C Genotype 1 [Phase 1, Phase 2]
Phase 1/2 study of CF102 (piclidenoson) in chronic hepatitis C genotype 1 has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2015-04-10Clinical Trial Update: TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy [Phase 3]
Phase 3 trial results comparing TMC435HPC3001 with telaprevir, both given with pegylated interferon alfa-2a and ribavirin, in chronic hepati…
-
CLINICAL_TRIALS trial_result · 2015-04-08Clinical Trial Update: Post-marketing Surveillance of Children With Chronic Hepatitis C Treated With Intron A (Vial or Pen) and Rebetol (Study P04397)(TERMINATED)
A post-marketing surveillance study of children with chronic hepatitis C treated with Intron A (interferon alfa-2b) and Rebetol (ribavirin) …
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: Viral Kinetics in HCV Clearance in Subjects With Hemophilia [Phase 1]
Phase 1 clinical trial evaluating viral kinetics of hepatitis C virus clearance in people with hemophilia; results were posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-04-06Clinical Trial Update: The Effect of Adding Metformin to the Treatment of Hepatitis C [Phase 4]
A Phase 4 clinical trial evaluated whether adding metformin to standard hepatitis C therapy affects outcomes; the study has completed.
-
CLINICAL_TRIALS trial_result · 2015-04-03Clinical Trial Update: Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients [Phase 4]
Phase 4 clinical trial evaluating switching to Certican (everolimus) for Hepatitis C viremia in adult kidney transplant recipients has compl…
-
CLINICAL_TRIALS trial_result · 2015-03-31Clinical Trial Update: Hepatitis C Rimantadine and Antiviral Combination Therapy
A completed clinical trial evaluating rimantadine in combination with antiviral therapy for hepatitis C.
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV [Phase 3]
Phase 3 trial evaluating ledipasvir/sofosbuvir fixed-dose combination with and without ribavirin for chronic hepatitis C, completed with res…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical Trial
Three-year follow-up results from participants in a prior Lambda (BMS-914143) chronic hepatitis C trial, summarizing long-term safety and ou…
-
CLINICAL_TRIALS research · 2015-03-26Clinical Trial Update: Birth-Cohort Evaluation to Advance Screening and Testing for Hepatitis C [NA]
This clinical trials update describes a birth-cohort evaluation intended to improve Hepatitis C screening and testing, sponsored by the Nati…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Efficacy and Safety of Sofosbuvir Plus Ribavirin in Japanese Adults With Chronic Genotype 2 HCV Infection [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of combining sofosbuvir with ribavirin in Japanese adults with chronic hepatitis C infect…
-
CLINICAL_TRIALS trial_result · 2015-03-24Clinical Trial Update: Ribavirin Loading Dose or Priming and Concentration Targeting for HCV Genotype 1 [Phase 3]
Phase 3 trial evaluating ribavirin loading dose/priming and concentration targeting for Hepatitis C genotype 1 has completed.